Cargando…

Quantitative Dynamic (18)F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors

SIMPLE SUMMARY: The reliable and early during-the-course-of-treatment assessment of tumor response to the novel immunotherapeutic agents is a matter of debate, posing relevant challenges to conventional imaging modalities. In this prospective study, including 25 metastatic melanoma patients, we expl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sachpekidis, Christos, Hassel, Jessica C., Kopp-Schneider, Annette, Haberkorn, Uwe, Dimitrakopoulou-Strauss, Antonia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957728/ https://www.ncbi.nlm.nih.gov/pubmed/33804417 http://dx.doi.org/10.3390/cancers13051019

Ejemplares similares

Interim [(18)F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Assessment of early metabolic progression in melanoma patients under immunotherapy: an (18)F-FDG PET/CT study
por: Sachpekidis, Christos, et al.
Publicado: (2021)

The prognostic value of [(18)F]FDG PET/CT based response monitoring in metastatic melanoma patients undergoing immunotherapy: comparison of different metabolic criteria
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Can physiologic colonic [(18)F]FDG uptake in PET/CT imaging predict response to immunotherapy in metastatic melanoma?
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Application of the long axial field-of-view PET/CT with low-dose [(18)F]FDG in melanoma
por: Sachpekidis, Christos, et al.
Publicado: (2022)

Quantitative, Dynamic (18)F-FDG PET/CT in Monitoring of Smoldering Myeloma: A Case Report
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Fractal and Multifractal Analysis of PET-CT Images for Therapy Assessment of Metastatic Melanoma Patients under PD-1 Inhibitors: A Feasibility Study
por: Kosmou, Anastasia, et al.
Publicado: (2021)

Fractal and multifractal analysis of PET/CT images of metastatic melanoma before and after treatment with ipilimumab
por: Breki, Christina-Marina, et al.
Publicado: (2016)

The prognostic significance of [(18)F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
por: Sachpekidis, Christos, et al.
Publicado: (2021)

Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined (18)F-FDG and (18)F-FLT PET/CT imaging
por: Sachpekidis, C., et al.
Publicado: (2018)

Can (18)F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Application of an artificial intelligence-based tool in [(18)F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2023)

Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient
por: Sachpekidis, Christos, et al.
Publicado: (2017)

Retrospective Side Effect Profiling of the Metastatic Melanoma Combination Therapy Ipilimumab-Nivolumab Using Adverse Event Data
por: Soldatos, Theodoros G., et al.
Publicado: (2018)

Long axial field of view (LAFOV) PET-CT: implementation in static and dynamic oncological studies
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2023)

Imaging therapy response of gastrointestinal stromal tumors (GIST) with FDG PET, CT and MRI: a systematic review
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2017)

Complete Metabolic Response in FDG-PET-CT Scan before Discontinuation of Immune Checkpoint Inhibitors Correlates with Long Progression-Free Survival
por: Schank, Timo E., et al.
Publicado: (2021)

Quantitative approaches of dynamic FDG-PET and PET/CT studies (dPET/CT) for the evaluation of oncological patients
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2012)

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI
por: Papamichail, Dimitris, et al.
Publicado: (2019)

Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Kinetic modeling and parametric imaging with dynamic PET for oncological applications: general considerations, current clinical applications, and future perspectives
por: Dimitrakopoulou-Strauss, Antonia, et al.
Publicado: (2020)

Neoadjuvant Pazopanib Treatment in High-Risk Soft Tissue Sarcoma: A Quantitative Dynamic (18)F-FDG PET/CT Study of the German Interdisciplinary Sarcoma Group
por: Sachpekidis, Christos, et al.
Publicado: (2019)

Digital PET/CT allows for shorter acquisition protocols or reduced radiopharmaceutical dose in [(18)F]-FDG PET/CT
por: Alberts, Ian, et al.
Publicado: (2021)

Positron Emission Tomography in Merkel Cell Carcinoma
por: Sachpekidis, Christos, et al.
Publicado: (2020)

Characterization of multiple myeloma osseous lesions and diffuse infiltration pattern by 18F-FDG-PET/CT, static MRI and diffusion-weighted MR Imaging (DWI-MRI): a comparative multimodality imaging study
por: Mosebach, J, et al.
Publicado: (2014)

PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin α(v)β(3) Receptors
por: Liolios, Christos, et al.
Publicado: (2021)

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Hybrid imaging with [(68)Ga]PSMA-11 PET-CT and PET-MRI in biochemically recurrent prostate cancer
por: Glemser, P. A., et al.
Publicado: (2022)

(18)F-FDG PET-CT for Staging of Conjunctival Melanoma
por: Damian, Andres, et al.
Publicado: (2013)

Detection of a primary tumor in the area of the renal artery with (18)F-FDG PET/CT in a patient with metastatic undifferentiated sarcoma and a history of mid-aortic syndrome: A case report
por: Sachpekidis, Christos, et al.
Publicado: (2016)

Comparison of functional imaging in multiple myeloma patients: Indication for hybrid-imaging with PET/MRI?
por: Mosebach, J, et al.
Publicado: (2015)

Colonic Malignant Melanoma: (18)F-FDG PET/CT Findings
por: Kaya, Eser, et al.
Publicado: (2018)

Incidental SARS-CoV-2-related findings in asymptomatic patients in [(18)F]-FDG-PET/CT—potential insights
por: Alberts, Ian, et al.
Publicado: (2020)

Mapping heterogeneity in glucose uptake in metastatic melanoma using quantitative (18)F-FDG PET/CT analysis
por: de Heer, Ellen C., et al.
Publicado: (2018)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

Cardiac Metastasis of Malignant Melanoma Detected by (18)F-FDG PET/CT
por: Zhang, Hongzhe, et al.
Publicado: (2023)

Immunotherapy Monitoring with Immune Checkpoint Inhibitors Based on [(18)F]FDG PET/CT in Metastatic Melanomas and Lung Cancer
por: Lopci, Egesta
Publicado: (2021)

Baker’s Cyst on F-18 FDG PET/CT in a Patient with Ocular Melanoma
por: Cayvarlı, Hakan, et al.
Publicado: (2012)

Ruptured epidermal cyst mimicking cutaneous melanoma on F-18 FDG PET/CT
por: Nguyen, Ba D., et al.
Publicado: (2015)

Comparison of (18)F-FDG PET/CT and ultrasound in staging of patients with malignant melanoma
por: Weber, Philipp, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lf7367s885efvsuksl3bcqj4hh